A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Sunitinib|DRUG: paclitaxel|DRUG: bevacizumab|DRUG: paclitaxel
Sponsor: Pfizer